Literature DB >> 3022499

Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain.

K Kashihara, M Sato, Y Fujiwara, T Ogawa, K Fukuda, S Otsuki.   

Abstract

The effects of intermittent and continuous treatment with haloperidol (HPD) on dopamine turnover in the rat brain were studied. Each rat was treated with HPD for 14 days by either once daily intraperitoneal injections (2 mg/kg/day) (intermittent HPD group) or continuous infusion by a subcutaneously implanted pump which was adjusted to release 28 mg/kg of HPD over 14 days (continuous HPD group). Seven days after cessation of injections or removal of the pump, the regional changes in DA turnover following an acute dose of HPD (1 mg/kg, intraperitoneally) were examined. The continuous HPD group showed more prominent tolerance to HPD effect of augmenting DA turnover than the intermittent HPD group. It is presumed that continuously administered HPD produces greater tolerance to the acute effect of HPD than intermittently administered HPD.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022499

Source DB:  PubMed          Journal:  Yakubutsu Seishin Kodo        ISSN: 0285-5313


  3 in total

1.  Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia.

Authors:  Cassidy L Moody; Adam J Funk; Emily Devine; Ryan C Devore Homan; Detlev Boison; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

2.  Dysregulation of the unfolded protein response (UPR) in the dorsolateral prefrontal cortex in elderly patients with schizophrenia.

Authors:  Pitna Kim; Madeline R Scott; James H Meador-Woodruff
Journal:  Mol Psychiatry       Date:  2019-10-02       Impact factor: 15.992

3.  Cell-subtype-specific changes in adenosine pathways in schizophrenia.

Authors:  Sinead Marie O'Donovan; Courtney Sullivan; Rachael Koene; Emily Devine; Kathryn Hasselfeld; Cassidy Lynn Moody; Robert Erne McCullumsmith
Journal:  Neuropsychopharmacology       Date:  2018-02-26       Impact factor: 7.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.